Q1 2024 13F Holders as of 3/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
64.4M
-
Number of holders
-
162
-
Total 13F shares, excl. options
-
65.1M
-
Shares change
-
+7.29M
-
Total reported value, excl. options
-
$436M
-
Value change
-
+$50.2M
-
Put/Call ratio
-
2.01
-
Number of buys
-
82
-
Number of sells
-
-80
-
Price
-
$6.70
Significant Holders of AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) as of Q1 2024
198 filings reported holding CDMO - AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share as of Q1 2024.
AVID BIOSERVICES, INC. - Common Stock, par value $0.001 per share (CDMO) has 162 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 65.1M shares
.
Largest 10 shareholders include STATE STREET CORP (5.85M shares), BlackRock Inc. (5.18M shares), MILLENNIUM MANAGEMENT LLC (4.4M shares), VANGUARD GROUP INC (3.67M shares), AltraVue Capital, LLC (3.16M shares), 12 West Capital Management LP (2.75M shares), Royal Bank of Canada (2.63M shares), SNYDER CAPITAL MANAGEMENT L P (2.18M shares), PALISADE CAPITAL MANAGEMENT, LP (2.17M shares), and PUNCH & ASSOCIATES INVESTMENT MANAGEMENT, INC. (1.93M shares).
This table shows the top 162 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.